Tania F. Bahamondez-Canas

Dr. Tania F. Bahamondez-Canas

Facultad de Farmacia, University of Valparaíso, Valparaíso, Chile
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2018 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
HZHairui Zhang
Hairui Zhang
Tania F. Bahamondez-CanasTania F. Bahamondez-Canas
Tania F. Bahamondez-Canas
YZYajie Zhang
Yajie Zhang
JLJasmim Leal
Jasmim Leal
Hugh D.C. SmythHugh D.C. Smyth
Hugh D.C. Smyth

30 April 2019 in Biomedicines
Verified
Journal Article
Open access
PDF file
Tania F. Bahamondez-CanasTania F. Bahamondez-Canas
Tania F. Bahamondez-Canas
LHLara Heersema
Lara Heersema
Hugh D.C. SmythHugh D.C. Smyth
Hugh D.C. Smyth
Biofilm infections have gained recognition as an important therapeutic challenge in the last several decades due to their relationship with the chronicity of infectious diseases. Studies of novel therapeutic treatments targeting infections require the development and use of models to mimic the formation and characteristics of biofilms within host tissues. Due to the diversity of reported in vitro models and lack of consensus, this review aims to provide a summary of in vitro models currently used in research. In particular, we review the various reported in vitro models of Pseudomonas aeruginosa biofilms due to its high clinical impact in chronic wounds and in other chronic infections. We assess advances in in vitro models that incorporate relevant multispecies biofilms found in infected wounds, such as P. aeruginosa with Staphylococcus aureus, and additional elements such as mammalian cells, simulating fluids, and tissue explants in an attempt to better represent the physiological conditions found at an infection site. It is hoped this review will aid researchers in the field to make appropriate choices in their proposed studies with regards to in vitro models and methods.

1 January 2018 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Tania F. Bahamondez-CanasTania F. Bahamondez-Canas
Tania F. Bahamondez-Canas
ZCZhengrong Cui
Zhengrong Cui

7 March 2018 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
Tania F. Bahamondez-CanasTania F. Bahamondez-Canas
Tania F. Bahamondez-Canas
HZHairui Zhang
Hairui Zhang
FTFrederic Tewes
Frederic Tewes
JLJasmim Leal
Jasmim Leal
HSHugh D. C. Smyth
Hugh D. C. Smyth

18 August 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
BBBeatriz Behrend-Keim
Beatriz Behrend-Keim
ACAlmendra Castro-Muñoz
Almendra Castro-Muñoz
LMLuis Monrreal-Ortega
Luis Monrreal-Ortega
BÁBárbara Ávalos-León
Bárbara Ávalos-León
CCCarolina Campos-Estrada
Carolina Campos-Estrada
DMDaniel Moraga-Espinoza
Daniel Moraga-Espinoza

2 January 2018 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
Tania F. Bahamondez-CanasTania F. Bahamondez-Canas
Tania F. Bahamondez-Canas
Hugh D.C. SmythHugh D.C. Smyth
Hugh D.C. Smyth